Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00360035
Status:
COMPLETED
Last Update Posted:
2013-08-26
First Post:
2006-08-01
Brief Title:
Safety and Efficacy of Obatoclax Mesylate GX15-070MS in the Treatment of Myelofibrosis With Myeloid Metaplasia
Sponsor:
Gemin X
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07
Start Date Type:
None
Primary Completion Date:
2008-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-01
First Submit QC Date:
August 1 2006
Study First Post Date:
2006-08-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-08-16
Disp First Submit QC Date:
August 16 2013
Disp First Post Date:
2013-08-26
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-08-16
Last Update Post Date:
2013-08-26
Last Update Post Date Type:
ESTIMATED